Status:
COMPLETED
Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumonia
Lead Sponsor:
UPECLIN HC FM Botucatu Unesp
Conditions:
Community-Acquired Pneumonia
Eligibility:
All Genders
2-5 years
Phase:
PHASE4
Brief Summary
Objective: To compare the clinical effectiveness and hospital costs, the initial empirical treatment, Oxacillin / Ceftriaxone and Amoxicillin / Clavulanate in children with Community Acquired Pneumoni...
Detailed Description
eligibility: Children aged two months to five years with diagnosis of severe community acquired pneumonia, requiring hospitalization. Outcomes measures: time to clinical improvement (respiratory rate...
Eligibility Criteria
Inclusion
- children aged from 2 months to 5 years
- children diagnosed with severe community-acquired pneumonia, who require hospitalization.
Exclusion
- chronical diseases
- severe comorbidities
- children admitted at PICU
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT01166932
Start Date
April 1 2005
End Date
April 1 2009
Last Update
November 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cristiane Franco Ribeiro
Botucatu, São Paulo, Brazil, 18.618-970